ABOUT: ABOUT THIS SITE
Learn Who This Site Is Designed For & Why It's Important For Women.
ABOUT THIS SITE
Who is this site designed for?
The abortionpillrisks.org website is designed for patients, families, researchers, professionals, or the general public that have an interest in learning about the facts and health risks of mifepristone (otherwise known as the Abortion Pill or RU-486) and misoprostol for the termination of early pregnancy.
This information is also meant for readers with a basic knowledge of reproductive health and may also serve as an introduction to those with no prior knowledge about Medical Abortion with mifepristone and misoprostol.
Information referenced in this site is derived from the United States Food and Drug Administration's (FDA) website, U.S. Government publications, reproductive health resources, medical abortion provider publications, and international medical and research journals.
Why is this site important for women?
It is important for women to understand how to assess medical abortion and determine the relative value of risk versus the benefit. Women and the general public may be unsure who to believe.
"An important aspect of medical abortion risk-perception is based on the amount of trust a woman has in her health care provider or the drug company that has control of the perceived hazard or health risk."
This Site Will Emphasize Medical Abortion Health Risks By:
- Providing referenced factual and educational information on medical abortion with mifepristone and misoprostol for early pregnancy termination.
- Explaining Health Risks and Risk Warnings associated with medical abortion.
- Detailing the differences in the FDA approved regimen and how providers are using alternative regimens the FDA does not recognize for safety and effectiveness.
- Referencing how to report serious and life-threatening injuries to the FDA’s Reporting System (MedWatch) that monitors and communicates evolving health risks.
- Providing an educational animated video on: Abortion Pill Risks, Medical Abortion with Mifepristone and Misoprostol.
Page Last Updated: 9/27/2011